| Title: |
Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics and Telepsychiatry Use During COVID-19 Pandemic |
| Authors: |
Bessonova, Leona; Keane, Elizabeth; Achtyes, Eric; Harvey, Philip D.; Kane, John M.; Saklad, Stephen R.; Trotter, Jeffrey; Claxton, Amy; Hatfield, Tiffany; McGrory, James; Noori, Wahidullah; O’Sullivan, Amy K.; Biber, Joshua E.; Kessler, Asia Sikora; Yarlas, Aaron; Velligan, Dawn I. |
| Source: |
CNS Spectrums ; volume 27, issue 2, page 230-230 ; ISSN 1092-8529 2165-6509 |
| Publisher Information: |
Cambridge University Press (CUP) |
| Publication Year: |
2022 |
| Description: |
Background The COVID-19 pandemic substantially impacted care of patients with schizophrenia treated with long-acting injectable antipsychotics (LAIs). This study examined how clinics adapted operations to maintain a standard of care for these patients after pandemic onset. Methods Online surveys were completed in October-November 2020 by one principal investigator (PI) or PI-appointed designee at 35 clinics participating in OASIS (NCT03919994). Items concerned pandemic impacts on clinic operations, particularly telepsychiatry, and on the care of patients with schizophrenia treated with LAIs. Results All 35 clinics reported using telepsychiatry; 20 (57%) implemented telepsychiatry after pandemic onset. Telepsychiatry visits increased from 12%-15% to 45%-69% across outpatient visit types after pandemic onset; frequency of no-show and/or canceled telepsychiatry visits decreased by approximately one-third. Nearly half of clinics increased the frequency of telepsychiatry visits for patients with schizophrenia treated with LAIs. Approximately one-third of participants each reported switching patients treated with LAIs to longer injection interval LAIs or to oral antipsychotics. The most common system/clinic- and patient-related barrier for telepsychiatry visits was lower reimbursement rate and access to technology/reliable internet, respectively. Almost all participants (94%) were satisfied with telepsychiatry for maintaining care of patients with schizophrenia treated with LAIs; most predicted a hybrid of telepsychiatry and office visits post-pandemic. Conclusions Changes made by clinics after pandemic onset were viewed by almost all participants as satisfactory for maintaining a standard of care for patients with schizophrenia treated with LAIs. Most participants predicted continuing telepsychiatry to support patient care post-pandemic; equitable access to telepsychiatry will be important in this regard. Funding Alkermes, Inc. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1017/s1092852922000256 |
| Availability: |
https://doi.org/10.1017/s1092852922000256; https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S1092852922000256 |
| Rights: |
https://www.cambridge.org/core/terms |
| Accession Number: |
edsbas.DE3362BB |
| Database: |
BASE |